Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,190 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05802329RecruitingPhase 1
Testing eye injections for diabetic macular swelling
This Phase 1 study tests the safety and early effectiveness of OCU200 eye injections in people with diabetic macular edema (DME) that affects the center of vision. It may help by reducing the eye swelling that blurs vision from diabetes.
Deerfield Beach, FloridaAges 18 years+ - NCT02986984Recruiting
Kidney biopsy study for people with diabetic kidney disease
This study aims to learn more about diabetic nephropathy (kidney problems caused by diabetes) using planned kidney tissue samples. You may benefit by helping researchers understand the disease better, and you may be eligible if you already have a medically needed kidney biopsy scheduled.
Little Rock, ArkansasAges 18–100 - NCT03022682Recruiting
Study of inflammation and metabolism across diabetes and weight
This is an observational study that follows generally healthy adults to understand how inflammation, diabetes (type 2), and weight/metabolic health relate to each other. It may help researchers figure out why different groups (including different ethnic backgrounds) have different health risks.
San Francisco, CaliforniaAges 18–75 - NCT03587948Recruiting
Diabetes eye study for teens with diabetes
This study looks at how diabetes affects the eyes in children and teens. It may help doctors better detect or understand eye problems earlier in people with diabetes.
Shanghai, Shanghai MunicipalityAges 5–18 - NCT04547439RecruitingPhase 2
Melatonin for diabetic eye disease and better sleep
This Phase 2 study tests whether melatonin can improve sleep and possibly outcomes related to diabetic retinopathy (damage to the retina from diabetes). It also checks whether it affects related symptoms while keeping people safe.
Chicago, IllinoisAges 40–65 - NCT04916457Recruiting
Studying skin germs in diabetes-related foot skin problems
This study collects skin samples from people with and without type 2 diabetes, especially around foot skin problems, to learn how skin “micro-germs” differ. The goal is to better understand what’s going on in diabetic skin lesions and possibly guide future care.
Guangzhou, GuangdongAges 18–80 - NCT05010356Recruiting
Testing insulin sensitivity after breast cancer treatment
This study looks at how well your body uses insulin (a hormone that helps move sugar from the blood into cells) after breast cancer treatment. It may help researchers understand whether insulin sensitivity changes after chemotherapy and could guide future health monitoring.
Copenhagen, DKAges 20–45 - NCT05544019RecruitingPhase 1
Testing an investigational drug for mature B-cell cancers
This early (Phase 1) study tests SGR-1505, an experimental treatment, in people with certain mature B-cell cancers. It’s mainly designed to see how the drug works in the body and to check safety, and it may offer an option if standard treatments aren’t enough.
Gilbert, ArizonaAges 18 years+ - NCT05544266Recruiting
Study rare diabetes patterns to better guide diagnosis
This study looks at people who may have a “non-typical” form of diabetes, including rare genetic causes or unusual symptoms. It may help your care team understand what type of diabetes you have and whether specific genetic testing could explain it.
Aurora, ColoradoAges Any age - NCT05654467RecruitingPhase 2
Oral polio vaccine study for young children in Panama
This trial tests a new oral polio vaccine in children and babies in Panama. The goal is to see if it is safe and helps the body build protection against polio.
Panama CityAges 1 day–4 years - NCT06305416RecruitingPhase 3
Ranibizumab for diabetic macular edema
This trial tests an injection called Ranibizumab (10 mg/ml) to treat diabetic macular edema, a condition where fluid builds up in the center of the retina and causes blurry vision. The goal is to see if the drug is safe and effective at improving vision.
DhakaAges 18 years+ - NCT06479577Recruiting
Comparing ultrasound and laser therapy for diabetic foot pain
This study compares two physical therapy methods (ultrasound and high-intensity laser therapy) to see which one better reduces nerve pain, improves strength, and boosts quality of life in people with diabetic foot pain.
Bahawalpur, Punjab ProvinceAges 50–75 - NCT06487832Recruiting
Effect of diabetes drug on brain response to insulin
This study tests whether a GLP-1 receptor agonist (a type of diabetes medicine) changes how the brain responds to insulin in people with different body sizes. It may help understand if this drug can improve brain function related to insulin.
TübingenAges 18–70 - NCT06540690Recruiting
Healing after gum graft surgery: diabetic vs non-diabetic
This study looks at how well the roof of the mouth heals after a small piece is taken for a gum graft. It compares healing in people with type 2 diabetes to healing in people without diabetes. The goal is to see if diabetes affects recovery.
São José dos Campos, São PauloAges 18–80 - NCT06550596Recruiting
Amnion membrane for diabetic foot ulcers
This trial tests a wound covering made from donated amniotic tissue (dehydrated human amnion membrane) placed on a diabetic foot ulcer that isn't healing. It aims to see if adding this membrane to standard wound care helps the ulcer close faster.
Thousand Oaks, CaliforniaAges 18 years+ - NCT06668935Recruiting
Using a continuous glucose monitor to help stick with GLP-1 meds
This study tests whether using a continuous glucose monitor (CGM) like the FreeStyle Libre 3 helps people with type 2 diabetes stay on their new GLP-1 or GIP/GLP-1 medication longer. You must be starting a GLP-1 or GIP/GLP-1 drug for the first time and not already using a CGM.
Jacksonville, FloridaAges 18 years+ - NCT06916663Recruiting
Upper body vs. combined exercise during diabetic foot ulcer treatment
This trial compares two exercise programs for people with diabetic foot ulcers: one that uses only upper body exercises and one that combines upper body with non-weight bearing lower body exercises. The goal is to see which approach helps healing while keeping weight off the foot.
CairoAges 18–65 - NCT07022418RecruitingPhase 2
Formoterol for diabetic kidney disease
This trial tests if a drug called formoterol (usually used for asthma) can help protect the kidneys in people with type 2 diabetes and early-to-moderate kidney disease. It may offer a new way to slow kidney damage.
Charleston, South CarolinaAges 18–75 - NCT07122726Recruiting
Balance exercises for fall prevention in diabetes
This study tests whether adding special movement exercises (called proprioceptive neuromuscular facilitation) to standard Otago exercises can help improve balance and reduce the risk of falls in people with type 2 diabetes who have nerve damage in their feet.
IslamabadAges 50–75 - NCT07189936RecruitingPhase 2
Testing 2-HOBA for Immune Issues in Long COVID with POTS
This trial tests if a medication called 2-HOBA can help with ongoing immune system issues in people with Long COVID who also have POTS. It aims to reduce fatigue and other symptoms by calming overactive immune responses.
Nashville, TennesseeAges 18 years+ - NCT07245667RecruitingPhase 2
Tolnaftate stick for athlete's foot study
This trial tests a medicated stick for athlete's foot (tinea pedis). It aims to see if the treatment is safe and works well.
Framingham, MassachusettsAges 16 years+ - NCT07298408RecruitingPhase 1/Phase 2
CBD for Diabetic Nerve Pain: A Pilot Study
This trial tests whether a daily dose of CBD (a cannabis compound) can help reduce nerve pain from type 2 diabetes. It's a small, early study to see if it's safe and effective.
Tallahassee, FloridaAges 40–70 - NCT07339852Recruiting
Pharmacist-led diabetes care in community pharmacies
This study tests whether a pharmacist-led program can help people with type 2 diabetes who are not meeting their blood sugar goals. The goal is to see if working with a pharmacist in your local pharmacy can improve your diabetes management.
Edmonton, AlbertaAges 18 years+ - NCT07556354Recruiting
Diabetes Education Through Faith Communities in Birmingham
This study tests whether faith-based organizations in Birmingham can effectively teach people with diabetes or prediabetes how to manage their condition better. If you have diabetes or prediabetes and have never taken a formal diabetes education class, this program might help you learn practical daily management skills.
Birmingham, AlabamaAges 18 years+
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,190 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.